Evaluating surrogate endpoints (Q78726678)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505247 AND SRC:MED&resulttype=core&format=json

16 December 2019

title

Evaluating surrogate endpoints (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505247 AND SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Michael D Hughes

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505247 AND SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 December 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505247 AND SRC:MED&resulttype=core&format=json

Contemporary Clinical Trials

16 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505247 AND SRC:MED&resulttype=core&format=json

16 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505247 AND SRC:MED&resulttype=core&format=json

16 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505247 AND SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

703-707

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505247 AND SRC:MED&resulttype=core&format=json

Statistical challenges in the evaluation of surrogate endpoints in randomized trials

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0197-2456(02)00264-7

7 January 2021

Surrogate markers and joint models for longitudinal and survival data

1 reference

https://api.crossref.org/works/10.1016/S0197-2456(02)00264-7

7 January 2021

Estimating the proportion of treatment effect explained by a surrogate marker

1 reference

https://api.crossref.org/works/10.1016/S0197-2456(02)00264-7

7 January 2021

CD4 cell count as a surrogate endpoint in HIV clinical trials: a meta-analysis of studies of the AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016/S0197-2456(02)00264-7

7 January 2021

Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research

1 reference

https://api.crossref.org/works/10.1016/S0197-2456(02)00264-7

7 January 2021

Increasing efficiency from censored survival data by using random effects to model longitudinal covariates

1 reference

https://api.crossref.org/works/10.1016/S0197-2456(02)00264-7

7 January 2021

Survival analysis using auxiliary variables via multiple imputation, with application to AIDS clinical trial data

1 reference

https://api.crossref.org/works/10.1016/S0197-2456(02)00264-7

7 January 2021

Surrogate endpoints in clinical trials: definition and operational criteria

1 reference

https://api.crossref.org/works/10.1016/S0197-2456(02)00264-7

7 January 2021

Surrogate end points in clinical trials: are we being misled?

1 reference

https://api.crossref.org/works/10.1016/S0197-2456(02)00264-7

7 January 2021

Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaborative Group

1 reference

https://api.crossref.org/works/10.1016/S0197-2456(02)00264-7

7 January 2021

Meta-analysis for the evaluation of potential surrogate markers

1 reference

https://api.crossref.org/works/10.1016/S0197-2456(02)00264-7

7 January 2021

On meta-analytic assessment of surrogate outcomes.

1 reference

https://api.crossref.org/works/10.1016/S0197-2456(02)00264-7

7 January 2021

10.1016/S0197-2456(02)00264-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505247 AND SRC:MED&resulttype=core&format=json

16 December 2019

1 reference